The gradual deterioration of the pancreatic β-cell function in type 2 diabetes mellitus (T2DM) patients prompts the progressive introduction of more complex treatments, including the initiation of insulin in many patients. Rapid-acting insulin analogs (aspart, lispro, and glulisine) show advantages over human regular insulin due to their rapid absorption, short duration, and higher maximum insu...
